heart stents, surgical tools and monitoring devices; and from still higher-margin prescription drugs targeting Crohn's disease (Remicade), cancer (Zytig a, Velcade), schizophrenia (Risperdal), diabetes (Invokana), psoriasis (Stela ra), migraines (Topamax), heart disease (Xarelto) and attention defici